blog.aids.gov − NIH’s Dr. Dieffenbach Shares Updates on HIV Vaccine Research from 2nd Day of AIDS 2016
|
July 19, 2016 : AIDS.gov Blog |
As the second day of the International AIDS Conference (AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via Facebook Live to get his thoughts on some of the day’s highlights. He is Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID)....[READ MORE]
NIH’S DR. DIEFFENBACH SHARES UPDATES ON HIV VACCINE RESEARCH FROM 2ND DAY OF AIDS 2016
July 19, 2016 •
By AIDS.gov As the second day of the International AIDS Conference (
AIDS 2016) came to a close in Durban, South Africa, we caught up with Dr. Carl Dieffenbach again via
Facebook Live 
to get his thoughts on some of the day’s highlights. He is Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (
NIAID).
This was “HIV vaccine day” at AIDS 2016, according to Dr. Dieffenbach, since there were several important presentations about advances in ongoing HIV vaccine research. These included details on the launch of a large vaccine trial that will involve 5,200 people in South Africa and elsewhere in sub-Saharan Africa.
In case you missed it, you can view the recorded version of the Facebook Live conversation with his colleague Anne Rancourt below.
Tune in to the
AIDS.gov Facebook page on Wednesday, July 20 at 6:30 PM Durban time/12:30 PM EST for our final conversation from AIDS 2016 with Carl on Facebook Live. Or watch the recording of that update later in the day.
Related posts:
- NIH’s Dr. Dieffenbach Shares Perspectives from First Day of AIDS 2016
- Research Update: NIH’s Dr. Dieffenbach on CROI 2016 (Video)
- Dr. Fauci and Dr. Wolitski Discuss Highlights of AIDS 2016
- Peace Corps’ Marie McLeod Shares Perspective from AIDS 2016
- NIH’s Dr. Carl Dieffenbach Shares Highlights from Start of CROI 2016 (Video)
.png)
No hay comentarios:
Publicar un comentario